These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 11036964

  • 1. Cost-utility analysis of second-line hormonal therapy in advanced breast cancer: a comparison of two aromatase inhibitors to megestrol acetate.
    Dranitsaris G, Leung P, Mather J, Oza A.
    Anticancer Drugs; 2000 Aug; 11(7):591-601. PubMed ID: 11036964
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Letrozole: a pharmacoeconomic review of its use in postmenopausal women with breast cancer.
    Dunn C, Keam SJ.
    Pharmacoeconomics; 2006 Aug; 24(5):495-517. PubMed ID: 16706574
    [Abstract] [Full Text] [Related]

  • 5. Letrozole: a review of its use in postmenopausal women with breast cancer.
    Simpson D, Curran MP, Perry CM.
    Drugs; 2004 Aug; 64(11):1213-30. PubMed ID: 15161328
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A summary of second-line randomized studies of aromatase inhibitors.
    Buzdar AU.
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):109-14. PubMed ID: 11850214
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. New aromatase inhibitors for breast cancer.
    Drug Ther Bull; 1997 Jul; 35(7):55-6. PubMed ID: 9282426
    [Abstract] [Full Text] [Related]

  • 12. Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate.
    Buzdar A, Douma J, Davidson N, Elledge R, Morgan M, Smith R, Porter L, Nabholtz J, Xiang X, Brady C.
    J Clin Oncol; 2001 Jul 15; 19(14):3357-66. PubMed ID: 11454883
    [Abstract] [Full Text] [Related]

  • 13. Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.
    Dombernowsky P, Smith I, Falkson G, Leonard R, Panasci L, Bellmunt J, Bezwoda W, Gardin G, Gudgeon A, Morgan M, Fornasiero A, Hoffmann W, Michel J, Hatschek T, Tjabbes T, Chaudri HA, Hornberger U, Trunet PF.
    J Clin Oncol; 1998 Feb 15; 16(2):453-61. PubMed ID: 9469328
    [Abstract] [Full Text] [Related]

  • 14. A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer.
    Jonat W, Howell A, Blomqvist C, Eiermann W, Winblad G, Tyrrell C, Mauriac L, Roche H, Lundgren S, Hellmund R, Azab M.
    Eur J Cancer; 1996 Mar 15; 32A(3):404-12. PubMed ID: 8814682
    [Abstract] [Full Text] [Related]

  • 15. Economic evaluation of antiaromatase agents in the second-line treatment of metastatic breast cancer.
    Verma S, Rocchi A.
    Support Care Cancer; 2003 Nov 15; 11(11):728-34. PubMed ID: 12883965
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Survival in patients with metastatic breast cancer: analysis of randomized studies comparing oral aromatase inhibitors versus megestrol.
    Messori A, Cattel F, Trippoli S, Vaiani M.
    Anticancer Drugs; 2000 Oct 15; 11(9):701-6. PubMed ID: 11129731
    [Abstract] [Full Text] [Related]

  • 18. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.
    Cohen MH, Johnson JR, Li N, Chen G, Pazdur R.
    Clin Cancer Res; 2002 Mar 15; 8(3):665-9. PubMed ID: 11895893
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cost effectiveness of letrozole versus anastrozole in postmenopausal women with HR+ early-stage breast cancer.
    Lipsitz M, Delea TE, Guo A.
    Curr Med Res Opin; 2010 Oct 15; 26(10):2315-28. PubMed ID: 20731528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.